• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普伐他汀可降低人体血清胆固醇、胆固醇前体甾醇、粪便类固醇及胆固醇吸收。

Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man.

作者信息

Vanhanen H, Kesäniemi Y A, Miettinen T A

机构信息

Second Department of Medicine, University of Helsinki, Finland.

出版信息

Metabolism. 1992 Jun;41(6):588-95. doi: 10.1016/0026-0495(92)90050-k.

DOI:10.1016/0026-0495(92)90050-k
PMID:1640845
Abstract

Serum lipids, and absorption, intestinal fluxes, fecal elimination, and synthesis of cholesterol were studied before and during 4 weeks of pravastatin treatment at a dose of 40 mg/d in heterozygous familial hypercholesterolemic (FH) patients without (control group, n = 7) and with an ileal bypass (IBP group, n = 6). The drug reduced serum total and low-density lipoprotein (LDL) cholesterol and LDL-apoprotein (apo)B levels up to 34%. Less-consistent decreases in intermediate-density lipoprotein (IDL) and very-low-density lipoprotein (VLDL) cholesterol were also seen. None of the control patients and two of the IBP patients became normolipidemic (LDL less than 4 mmol/L). Marked transient reductions in serum free-methylated-cholesterol precursors, and more-constant decreases in the esterified and total fractions, suggested that cholesterol synthesis was reduced shortly after the start of treatment. The decreases in total lathosterol and methylsterols were more extensive in the IBP group than in the control group. Serum plant sterol levels were slightly increased, with inconsistent elevations of cholestanol. Reduced fecal elimination of cholesterol and its precursors suggests that decreased cholesterol synthesis was mainly due to lowered bile acid production, particularly in the IBP group with markedly enhanced basal bile acid and cholesterol synthesis. The serum and fecal levels of cholesterol precursors, lathosterol in particular, were related to each other and were proportionate to the serum level and fecal elimination of cholesterol.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在40毫克/天剂量的普伐他汀治疗前及治疗4周期间,对杂合子家族性高胆固醇血症(FH)患者进行了研究,这些患者分为两组,一组无回肠旁路手术(对照组,n = 7),另一组有回肠旁路手术(IBP组,n = 6),研究内容包括血清脂质以及胆固醇的吸收、肠道通量、粪便排泄和合成情况。该药物使血清总胆固醇和低密度脂蛋白(LDL)胆固醇以及LDL-载脂蛋白(apo)B水平降低达34%。中间密度脂蛋白(IDL)和极低密度脂蛋白(VLDL)胆固醇也有不太一致的降低。对照组患者无一例血脂正常(LDL低于4毫摩尔/升),IBP组有两例血脂正常。血清游离甲基化胆固醇前体明显短暂降低,酯化和总部分则持续降低,这表明治疗开始后不久胆固醇合成减少。IBP组总羊毛甾醇和甲基甾醇的降低比对照组更显著。血清植物甾醇水平略有升高,胆甾烷醇升高情况不一致。胆固醇及其前体的粪便排泄减少表明胆固醇合成减少主要是由于胆汁酸生成降低,特别是在基础胆汁酸和胆固醇合成明显增强的IBP组。胆固醇前体的血清和粪便水平,尤其是羊毛甾醇,相互关联,且与血清胆固醇水平和粪便胆固醇排泄成比例。(摘要截短于250字)

相似文献

1
Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man.普伐他汀可降低人体血清胆固醇、胆固醇前体甾醇、粪便类固醇及胆固醇吸收。
Metabolism. 1992 Jun;41(6):588-95. doi: 10.1016/0026-0495(92)90050-k.
2
Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients.在普伐他汀治疗的高胆固醇血症患者中,谷甾烷醇酯喂养和新霉素引起的胆固醇吸收不良。
Eur J Clin Pharmacol. 1994;47(2):169-76. doi: 10.1007/BF00194968.
3
Hypolipidemic effect and mechanism of ketoconazole without and with cholestyramine in familial hypercholesterolemia.
Metabolism. 1991 Jan;40(1):35-41. doi: 10.1016/0026-0495(91)90189-4.
4
Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men.中年男性血清胆甾烷醇和植物甾醇水平与胆固醇代谢的关系
Metabolism. 1989 Feb;38(2):136-40. doi: 10.1016/0026-0495(89)90252-7.
5
Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination.
Atherosclerosis. 1995 Jun;115(2):135-46. doi: 10.1016/0021-9150(94)05474-w.
6
Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment.人类在喂食角鲨烯期间胆固醇的代谢变量:与消胆胺治疗的比较。
J Lipid Res. 1990 Sep;31(9):1637-43.
7
Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men.非胆固醇甾醇在预测高胆固醇血症男性患者辛伐他汀和氟伐他汀治疗胆固醇代谢反应中的适用性。
Nutr Metab Cardiovasc Dis. 2010 Jun;20(5):308-16. doi: 10.1016/j.numecd.2009.04.014. Epub 2009 Aug 19.
8
Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia.酮康唑对高胆固醇血症患者胆固醇前体及低密度脂蛋白动力学的影响。
J Lipid Res. 1993 Jan;34(1):59-67.
9
Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion.回肠切除术后脂蛋白中胆固醇前体含量增加。
Lipids. 1988 Oct;23(10):993-6. doi: 10.1007/BF02536349.
10
Cholesterol precursors and their diurnal rhythm in lipoproteins of patients with jejuno-ileal bypass and ileal dysfunction.
Metabolism. 1985 May;34(5):425-30. doi: 10.1016/0026-0495(85)90207-0.

引用本文的文献

1
Non-Cholesterol Sterol Concentrations as Biomarkers for Cholesterol Absorption and Synthesis in Different Metabolic Disorders: A Systematic Review.非胆固醇甾醇浓度作为不同代谢紊乱中胆固醇吸收和合成的生物标志物:系统评价。
Nutrients. 2019 Jan 9;11(1):124. doi: 10.3390/nu11010124.
2
The Impact of Egg Nutrient Composition and Its Consumption on Cholesterol Homeostasis.鸡蛋营养成分及其摄入量对胆固醇稳态的影响。
Cholesterol. 2018 Aug 23;2018:6303810. doi: 10.1155/2018/6303810. eCollection 2018.
3
Statins redux: A re-assessment of how statins lower plasma cholesterol.
他汀类药物再审视:对他汀类药物降低血浆胆固醇机制的重新评估
World J Diabetes. 2017 Jun 15;8(6):230-234. doi: 10.4239/wjd.v8.i6.230.
4
Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.他汀类药物可增加小鼠肝脏胆固醇的合成,并刺激粪便中胆固醇的排出。
J Lipid Res. 2016 Aug;57(8):1455-64. doi: 10.1194/jlr.M067488. Epub 2016 Jun 16.
5
Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.胆固醇合成/吸收标志物与阿托伐他汀降低冠心病高危患者胆固醇水平的疗效之间的关系。
J Lipid Res. 2013 Nov;54(11):3189-97. doi: 10.1194/jlr.P040360. Epub 2013 Aug 20.
6
Current views on genetics and epigenetics of cholesterol gallstone disease.当前关于胆固醇结石病的遗传学和表观遗传学观点。
Cholesterol. 2013;2013:298421. doi: 10.1155/2013/298421. Epub 2013 Apr 14.
7
Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid.在低剂量胆酸喂养的 Cyp7a1(-/-) 小鼠中,伴随胆汁酸池大小恢复的生化、分子和生理变化的描述。
Am J Physiol Gastrointest Liver Physiol. 2012 Jul 15;303(2):G263-74. doi: 10.1152/ajpgi.00111.2012. Epub 2012 May 24.
8
Phytosterols and phytosterolemia: gene-diet interactions.植物固醇和植物固醇血症:基因-饮食相互作用。
Genes Nutr. 2011 Feb;6(1):17-26. doi: 10.1007/s12263-010-0182-x. Epub 2010 Aug 28.
9
Plasma plant sterol levels do not reflect cholesterol absorption in children with Smith-Lemli-Opitz syndrome.血浆植物甾醇水平不能反映史密斯-利姆利-奥皮茨综合征患儿的胆固醇吸收情况。
J Pediatr. 2009 Apr;154(4):557-561.e1. doi: 10.1016/j.jpeds.2008.10.045. Epub 2008 Dec 21.
10
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.最大剂量阿托伐他汀和瑞舒伐他汀治疗对胆固醇合成及吸收标志物影响的比较
J Lipid Res. 2009 Apr;50(4):730-9. doi: 10.1194/jlr.P800042-JLR200. Epub 2008 Nov 30.